Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85,388 | 43,994 | 57,206 | 87,131 | 51,230 |
| Marketable Securities | 284,522 | 205,238 | 186,796 | 299,518 | 284,006 |
| Receivables | 39,618 | 49,036 | 60,831 | 36,533 | 51,313 |
| TOTAL | $422,791 | $311,713 | $319,021 | $436,837 | $401,848 |
| Non-Current Assets | |||||
| PPE Net | 11,919 | 6,173 | 5,943 | 8,596 | 10,927 |
| Investments And Advances | 0 | 29,285 | 108,416 | 32,634 | 65,013 |
| Other Non-Current Assets | 27,565 | 28,239 | 5,411 | 8,065 | 12,041 |
| TOTAL | $39,484 | $63,697 | $119,770 | $49,295 | $87,981 |
| Total Assets | $462,275 | $375,410 | $438,791 | $486,132 | $489,829 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,097 | 6,000 | 9,540 | 5,737 | 6,689 |
| Accrued Expenses | 18,339 | 20,936 | 22,429 | 14,159 | 15,920 |
| Other current liabilities | 35,076 | N/A | N/A | N/A | N/A |
| TOTAL | $62,787 | $29,827 | $36,172 | $24,157 | $22,609 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 182,753 | 24,249 | 3,190 | 6,395 | 4,728 |
| TOTAL | $182,753 | $24,249 | $3,190 | $6,395 | $4,728 |
| Total Liabilities | $245,540 | $54,076 | $39,362 | $30,552 | $27,337 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,059 | 20,797 | 20,325 | 20,079 | 19,726 |
| Common Shares | 211 | 208 | 202 | 201 | 197 |
| Retained earnings | -206,995 | -73,179 | 48,576 | 127,572 | 163,740 |
| Other shareholders' equity | -1,174 | -3,724 | -382 | 844 | 146 |
| TOTAL | $216,735 | $321,334 | $399,429 | $455,580 | $462,492 |
| Total Liabilities And Equity | $462,275 | $375,410 | $438,791 | $486,132 | $489,829 |